MITHRARING
As listed in the register: MITHRARING 0,120 MG/0,015 MG CADA 24 HORAS SISTEMA DE LIBERACION VAGINAL EFG
0,12 mg/0,015 mg · sistema de liberación vaginal
- Prescription only
- Urinary and reproductive system, hormones
- Active substance
- Etonogestrel + etinilestradiol
- Made by
- Novalon S.A.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | Novalon S.A. |
|---|---|
| Active substance | Etonogestrel + etinilestradiol |
| Used in | Urinary and reproductive system, hormones |
| Strength | 0,12 mg/0,015 mg |
| Form | sistema de liberación vaginal |
| Classification | G02BB01 · Urinary and reproductive system, hormones |
| Route | vía vaginal |
| Marketed | No — authorised but not currently marketed, according to the register |
| Generic | Yes — a generic medicine, according to the register |
| Name in the register | MITHRARING 0,120 MG/0,015 MG CADA 24 HORAS SISTEMA DE LIBERACION VAGINAL EFG |
| Nº Registro | 84449 |
Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30 · not reviewed by a clinician
Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA. Reuse terms: Aviso legal AEMPS.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.